News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
193 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (28807)
Month
January (2935)
February (2968)
March (2707)
April (2905)
May (3623)
June (2409)
July (2086)
August (2588)
September (2381)
October (3062)
November (1143)
Day
1 (86)
3 (15)
4 (48)
5 (127)
6 (193)
7 (194)
8 (195)
9 (1)
11 (65)
12 (179)
13 (158)
14 (111)
15 (154)
18 (92)
19 (92)
20 (119)
21 (99)
22 (68)
24 (15)
25 (85)
26 (125)
27 (76)
28 (174)
29 (117)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
Day
1
3
4
5
6
7
8
9
11
12
13
14
15
18
19
20
21
22
24
25
26
27
28
29
Brain cancer
FDA Greenlights Jazz’s Dordaviprone, First New Treatment for Ultra-Rare Brain Tumor
The small molecule drug, acquired by Jazz Pharmaceuticals in its $935 million Chimerix pick-up this spring, is intended for relapsed adult and pediatric patients with H3 K27M mutations.
August 6, 2025
·
2 min read
·
Dan Samorodnitsky
Podcast
FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, More
George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest rejection reportedly driven by FDA’s top cancer regulator Richard Pazdur; Merck’s $3 billion savings push claims 6,000 jobs; and Pfizer CEO Albert Bourla addresses President Donald Trump’s new threats around Most Favored Nation drug pricing.
August 6, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Lysoway Therapeutics Awarded Grant from The Michael J. Fox Foundation to Advance TRPML1 Agonist to Treat Parkinson’s Disease
August 6, 2025
·
1 min read
Press Releases
Bracco Imaging Receives Regulatory Approval in China for SonoVue® in the Assessment of Fallopian Tube Patency
August 6, 2025
·
4 min read
Press Releases
Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
August 6, 2025
·
5 min read
Press Releases
Nxera Launches Broad Proprietary Pipeline Targeting Obesity and Chronic Weight Management
August 6, 2025
·
5 min read
Press Releases
Contineum Therapeutics Reports Second-Quarter 2025 Financial Results; Updates Key Clinical Development Milestones
August 6, 2025
·
11 min read
Press Releases
Quantum-Si Reports Second Quarter 2025 Financial Results
August 6, 2025
·
14 min read
Press Releases
Gossamer Bio Announces Second Quarter 2025 Financial Results and Provides Business Update
August 6, 2025
·
9 min read
Press Releases
QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability
August 6, 2025
·
6 min read
Previous
2 of 20
Next
